SLN - Silence Therapeutics plc

QQQ $ 610.48 $ 0.00 (0 %)

DIA $ 469.25 $ 0.00 (0 %)

SPY $ 671.68 $ 0.00 (0 %)

TLT $ 92.15 $ 0.00 (0 %)

GLD $ 372.58 $ 0.00 (0 %)

Previous Close

$ 7.4

Open

$ 7.19

Bid

$ 7.23 x 100

Ask

$ 7.95 x 304

Day's Range

-- - --

52 Week Range

$ 1.97 - $ 18.72

Volume

324,055

Average Volume

Market Cap

349.53M

Beta (5Y Monthly)

$ 1.09

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-07-2025	06-30-2025	10-Q
2	05-08-2025	03-31-2025	10-Q
3	02-27-2025	12-31-2024	10-K

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

12 Health Care Stocks Moving In Tuesday's ...
10/21/2025 21:06:33

12 Health Care Stocks Moving In Tuesday's ...
10/21/2025 12:10:04

HC Wainwright & Co. Reiterates Buy on Sile...
09/16/2025 10:49:37

HC Wainwright & Co. analyst Patrick R. Trucchio reiterates Silence Therapeutics (NASDAQ:SLN) with a Buy and maintains $7...

Chardan Capital Maintains Buy on Silence T...
08/08/2025 11:57:30

Chardan Capital analyst Keay Nakae maintains Silence Therapeutics (NASDAQ:SLN) with a Buy and maintains $35 price target.

CORRECTION: Silence Therapeutics Q2 EPS $(...
08/07/2025 14:10:44

Silence Therapeutics (NASDAQ:SLN) reported quarterly losses of $(0.57) per share which missed the analyst consensus estimate of...

HC Wainwright & Co. Reiterates Buy on Sile...
06/13/2025 11:21:19

HC Wainwright & Co. analyst Patrick Trucchio reiterates Silence Therapeutics (NASDAQ:SLN) with a Buy and maintains $75 p...

Chardan Capital Maintains Buy on Silence T...
06/13/2025 10:50:49

Chardan Capital analyst Keay Nakae maintains Silence Therapeutics (NASDAQ:SLN) with a Buy and maintains $35 price target.

Silence Therapeutics Presents Additional D...
06/12/2025 20:02:22

Updated Phase 1 Data Presented at EHA 2025 Annual Meeting Reinforce Safety Profile, Efficacy Data and Dosing Convenience of Div...

12 Health Care Stocks Moving In Tuesday's ...
06/03/2025 21:05:58

12 Health Care Stocks Moving In Tuesday's ...
05/13/2025 12:10:18

Goldman Sachs Maintains Sell on Silence Th...
05/09/2025 18:13:56

Goldman Sachs analyst Richard Law maintains Silence Therapeutics (NASDAQ:SLN) with a Sell and lowers the price target from ...

Morgan Stanley Maintains Overweight on Sil...
05/09/2025 15:57:01

Morgan Stanley analyst Michael Ulz maintains Silence Therapeutics (NASDAQ:SLN) with a Overweight and lowers the price target...

Chardan Capital Maintains Buy on Silence T...
05/09/2025 10:45:46

Chardan Capital analyst Keay Nakae maintains Silence Therapeutics (NASDAQ:SLN) with a Buy and lowers the price target from $...

UPDATE: Silence Therapeutics Q1 EPADS $(0....
05/08/2025 14:08:09

HC Wainwright & Co. Reiterates Buy on Sile...
03/07/2025 11:59:10

HC Wainwright & Co. analyst Patrick Trucchio reiterates Silence Therapeutics (NASDAQ:SLN) with a Buy and maintains $75 p...

Morgan Stanley Maintains Overweight on Sil...
03/05/2025 14:08:57

Morgan Stanley analyst Michael Ulz maintains Silence Therapeutics (NASDAQ:SLN) with a Overweight and lowers the price target...

Deep Dive Into Silence Therapeutics Stock:...
03/04/2025 21:01:16

BMO Capital Maintains Outperform on Silenc...
03/04/2025 17:57:14

BMO Capital analyst Kostas Biliouris maintains Silence Therapeutics (NASDAQ:SLN) with a Outperform and lowers the price targ...

Goldman Sachs Maintains Sell on Silence Th...
03/04/2025 14:33:24

Goldman Sachs analyst Richard Law maintains Silence Therapeutics (NASDAQ:SLN) with a Sell and lowers the price target from ...

Silence Therapeutics FY EPS $(0.33) Up Fro...
02/27/2025 13:24:41

Silence Therapeutics (NASDAQ:SLN) reported quarterly losses of $(0.33) per share. This is a 32.65 percent increase over losses ...